| Andrew J Stephenson, MD | |
|
1226 E Water St, Syracuse, NY 13210-1155 | |
| (315) 478-4185 | |
| (315) 478-0840 |
| Full Name | Andrew J Stephenson |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 27 Years |
| Location | 1226 E Water St, Syracuse, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366478455 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lutheran Hospital Of Indiana | Fort wayne, IN | Hospital |
| Rush University Medical Center | Chicago, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Associated Medical Professionals Of Ny Pllc | 0749378123 | 62 |
| Lutheran Medical Group Llc | 4981751617 | 261 |
News Archive
Today, Insilico Medicine, Inc., a Baltimore-based company specializing in the application of artificial intelligence for drug discovery, biomarker development and aging research, announced a publication of a research paper titled "Population-specific biomarkers of human aging: a big data study using South Korean, Canadian and Eastern-European patient populations" in The Journal of Gerontology.
Health records have been sealed since 1996, when the Health Insurance Portability and Accountability Act (HIPAA) was signed into law to protect the privacy of personal health records. That protection applies not only to the charts of the living or recently deceased, but also to records dating to the 1700s and 1800s.
PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has begun Phase 1/2a clinical testing with its lead compound, Glymera(PB1023), in patients with Type 2 diabetes.
Mexico's border with America is clustered with clinics providing unusual treatments for cancer - alternatives to conventional medicine that claim to offer a complete cure, even for the terminally ill, in return for tens of thousands of dollars.
NewLink Genetics Corporation announces launching of an open-label, randomized, multi-institutional Phase 3 study in patients with borderline resectable or locally advanced unresectable pancreatic cancer.
› Verified 5 days ago
| Entity Name | Associated Medical Professionals Of Ny Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467659060 PECOS PAC ID: 0749378123 Enrollment ID: O20071119000351 |
News Archive
Today, Insilico Medicine, Inc., a Baltimore-based company specializing in the application of artificial intelligence for drug discovery, biomarker development and aging research, announced a publication of a research paper titled "Population-specific biomarkers of human aging: a big data study using South Korean, Canadian and Eastern-European patient populations" in The Journal of Gerontology.
Health records have been sealed since 1996, when the Health Insurance Portability and Accountability Act (HIPAA) was signed into law to protect the privacy of personal health records. That protection applies not only to the charts of the living or recently deceased, but also to records dating to the 1700s and 1800s.
PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has begun Phase 1/2a clinical testing with its lead compound, Glymera(PB1023), in patients with Type 2 diabetes.
Mexico's border with America is clustered with clinics providing unusual treatments for cancer - alternatives to conventional medicine that claim to offer a complete cure, even for the terminally ill, in return for tens of thousands of dollars.
NewLink Genetics Corporation announces launching of an open-label, randomized, multi-institutional Phase 3 study in patients with borderline resectable or locally advanced unresectable pancreatic cancer.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew J Stephenson, MD 100 Metropolitan Park Dr Ste 100, Liverpool, NY 13088-7112 Ph: (315) 870-9369 | Andrew J Stephenson, MD 1226 E Water St, Syracuse, NY 13210-1155 Ph: (315) 478-4185 |
News Archive
Today, Insilico Medicine, Inc., a Baltimore-based company specializing in the application of artificial intelligence for drug discovery, biomarker development and aging research, announced a publication of a research paper titled "Population-specific biomarkers of human aging: a big data study using South Korean, Canadian and Eastern-European patient populations" in The Journal of Gerontology.
Health records have been sealed since 1996, when the Health Insurance Portability and Accountability Act (HIPAA) was signed into law to protect the privacy of personal health records. That protection applies not only to the charts of the living or recently deceased, but also to records dating to the 1700s and 1800s.
PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has begun Phase 1/2a clinical testing with its lead compound, Glymera(PB1023), in patients with Type 2 diabetes.
Mexico's border with America is clustered with clinics providing unusual treatments for cancer - alternatives to conventional medicine that claim to offer a complete cure, even for the terminally ill, in return for tens of thousands of dollars.
NewLink Genetics Corporation announces launching of an open-label, randomized, multi-institutional Phase 3 study in patients with borderline resectable or locally advanced unresectable pancreatic cancer.
› Verified 5 days ago
Dr. Seetharam Bhat Kulthe Ramesh, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 550 Harrison St, Ste M, Syracuse, NY 13202 Phone: 315-464-1500 Fax: 315-464-6117 | |
Po N Lam, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1226 E Water St, Syracuse, NY 13210 Phone: 315-478-4185 Fax: 315-478-0840 | |
Dr. Mahmoud Chehab, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-5136 | |
Joel S Bass, M.D. Urology Medicare: Medicare Enrolled Practice Location: 1226 E Water St, Syracuse, NY 13210 Phone: 315-478-4185 Fax: 315-478-0840 | |
Giora Katz, MD Urology Medicare: Medicare Enrolled Practice Location: 550 Harrison St., Suite M, Syracuse, NY 13202 Phone: 315-464-1500 Fax: 315-464-6117 | |
Dr. Ruben Pinkhasov, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 550 Harrison St, Suite N, Syracuse, NY 13202 Phone: 315-464-1500 Fax: 315-464-6117 | |
Dr. Nick Wei-en Liu, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 750 East Adams St, Syracuse, NY 13210 Phone: 315-464-6106 Fax: 315-464-6117 |